159 related articles for article (PubMed ID: 26341587)
1. Overdiagnosis associated with breast cancer screening: A simulation study to compare lead-time adjustment methods.
Seigneurin A; Labarère J; Duffy SW; Colonna M
Cancer Epidemiol; 2015 Dec; 39(6):1128-35. PubMed ID: 26341587
[TBL] [Abstract][Full Text] [Related]
2. Mammography screening: A major issue in medicine.
Autier P; Boniol M
Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
[TBL] [Abstract][Full Text] [Related]
3. Overdiagnosis and overtreatment associated with breast cancer mammography screening: A simulation study with calibration to population-based data.
Seigneurin A; Labarère J; François O; Exbrayat C; Dupouy M; Filippi M; Colonna M
Breast; 2016 Aug; 28():60-6. PubMed ID: 27240167
[TBL] [Abstract][Full Text] [Related]
4. Incidence of breast cancer and estimates of overdiagnosis after the initiation of a population-based mammography screening program.
Coldman A; Phillips N
CMAJ; 2013 Jul; 185(10):E492-8. PubMed ID: 23754101
[TBL] [Abstract][Full Text] [Related]
5. Estimation of overdiagnosis using short-term trends and lead time estimates uncontaminated by overdiagnosed cases: Results from the Norwegian Breast Screening Programme.
Michalopoulos D; Duffy SW
J Med Screen; 2016 Dec; 23(4):192-202. PubMed ID: 26940963
[TBL] [Abstract][Full Text] [Related]
6. Extrapolation of pre-screening trends: Impact of assumptions on overdiagnosis estimates by mammographic screening.
Ripping TM; Verbeek AL; Ten Haaf K; van Ravesteyn NT; Broeders MJ
Cancer Epidemiol; 2016 Jun; 42():147-53. PubMed ID: 27153471
[TBL] [Abstract][Full Text] [Related]
7. Estimation of overdiagnosis in breast cancer screening using a non-homogeneous multi-state model: A simulation study.
Wu WY; Nyström L; Jonsson H
J Med Screen; 2018 Dec; 25(4):183-190. PubMed ID: 29153013
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study.
Autier P; Boniol M; Koechlin A; Pizot C; Boniol M
BMJ; 2017 Dec; 359():j5224. PubMed ID: 29208760
[No Abstract] [Full Text] [Related]
9. Breast cancer incidence trends in Norway and estimates of overdiagnosis.
van Luijt PA; Heijnsdijk EA; van Ravesteyn NT; Hofvind S; de Koning HJ
J Med Screen; 2017 Jun; 24(2):83-91. PubMed ID: 27754936
[TBL] [Abstract][Full Text] [Related]
10. Obligate Overdiagnosis Due to Mammographic Screening: A Direct Estimate for U.S. Women.
Hendrick RE
Radiology; 2018 May; 287(2):391-397. PubMed ID: 29267146
[TBL] [Abstract][Full Text] [Related]
11. Estimates of over-diagnosis of breast cancer due to population-based mammography screening in South Australia after adjustment for lead time effects.
Beckmann K; Duffy SW; Lynch J; Hiller J; Farshid G; Roder D
J Med Screen; 2015 Sep; 22(3):127-35. PubMed ID: 25896926
[TBL] [Abstract][Full Text] [Related]
12. As you like it: How the same data can support manifold views of overdiagnosis in breast cancer screening.
Njor SH; Paci E; Rebolj M
Int J Cancer; 2018 Sep; 143(6):1287-1294. PubMed ID: 29633249
[TBL] [Abstract][Full Text] [Related]
13. Missteps in Current Estimates of Cancer Overdiagnosis.
Lee CI; Etzioni R
Acad Radiol; 2017 Feb; 24(2):226-229. PubMed ID: 27894707
[TBL] [Abstract][Full Text] [Related]
14. Long-term relationships between screening rates, breast cancer characteristics, and overdiagnosis in US counties, 1975-2009.
Harding C; Pompei F; Burmistrov D; Wilson R
Int J Cancer; 2019 Feb; 144(3):476-488. PubMed ID: 30264887
[TBL] [Abstract][Full Text] [Related]
15. [Discrepancies and overdiagnosis in breast cancer organized screening. A "methodology" systematic review].
Gocko X; Leclerq M; Plotton C
Rev Epidemiol Sante Publique; 2018 Nov; 66(6):395-403. PubMed ID: 30316554
[TBL] [Abstract][Full Text] [Related]
16. Overdiagnosis in the population-based organized breast cancer screening program estimated by a non-homogeneous multi-state model: a cohort study using individual data with long-term follow-up.
Wu WY; Törnberg S; Elfström KM; Liu X; Nyström L; Jonsson H
Breast Cancer Res; 2018 Dec; 20(1):153. PubMed ID: 30558679
[TBL] [Abstract][Full Text] [Related]
17. Breast Cancer Screening in Denmark: A Cohort Study of Tumor Size and Overdiagnosis.
Jørgensen KJ; Gøtzsche PC; Kalager M; Zahl PH
Ann Intern Med; 2017 Mar; 166(5):313-323. PubMed ID: 28114661
[TBL] [Abstract][Full Text] [Related]
18. The Screening Illustrator: separating the effects of lead-time and overdiagnosis in mammography screening.
Lousdal ML; Møller MH; Kristiansen IS; Kalager M; Wisløff T; Støvring H
Eur J Public Health; 2018 Dec; 28(6):1138-1142. PubMed ID: 29796623
[TBL] [Abstract][Full Text] [Related]
19. The role of pre-invasive disease in overdiagnosis: A microsimulation study comparing mass screening for breast cancer and cervical cancer.
van Luijt PA; Rozemeijer K; Naber SK; Heijnsdijk EA; van Rosmalen J; van Ballegooijen M; de Koning HJ
J Med Screen; 2016 Dec; 23(4):210-216. PubMed ID: 27068430
[TBL] [Abstract][Full Text] [Related]
20. Estimation of overdiagnosis by detection to incidence ratio in cancer screening.
Hakama M; Malila N
J Med Screen; 2019 Sep; 26(3):135-138. PubMed ID: 30987504
[No Abstract] [Full Text] [Related]
[Next] [New Search]
